Insmed To Present at March 2026 Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Insmed (Nasdaq: INSM) announced management will present at two investor conferences in March 2026: the 46th Annual TD Cowen Healthcare Conference on March 2, 2026 at 9:50 a.m. ET and the Leerink Partners Global Healthcare Conference on March 10, 2026 at 8:00 a.m. ET.
Both presentations will be webcast live and archived for 30 days on the company investor relations website.
Details
News Market Reaction – INSM
On Feb 13, the day this news came out, INSM closed 1.77% above the previous close.
Data tracked by StockTitan Argus for the Feb 13 session.
Key Figures
- TD Cowen conference date
- March 2, 2026
- 46th Annual TD Cowen Healthcare Conference presentation
- TD Cowen time
- 9:50 a.m. ET
- Scheduled Insmed presentation slot
- Leerink conference date
- March 10, 2026
- Leerink Partners Global Healthcare Conference presentation
- Leerink time
- 8:00 a.m. ET
- Scheduled Insmed presentation slot
- Webcast archive period
- 30 days
- Duration webcasts remain available after events
- Conference edition
- 46th
- 46th Annual TD Cowen Healthcare Conference
Historical Context
-
Announced Q4 and full-year 2025 results call with business update.
-
Multiple TPIP abstracts at PVRI 2026, including Phase 3 design and Phase 2b data.
-
Strong 2025 revenue, BRINSUPRI launch progress, and key ENCORE/CEDAR timelines.
-
Planned presentation at J.P. Morgan Healthcare Conference with webcast access.
-
BiRCh Phase 2b CRSsNP study missed endpoints; program discontinued, new asset added.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- 46th Annual TD Cowen Healthcare Conference in
Boston , on Monday, March 2, 2026, at 9:50 a.m. ET. - Leerink Partners Global Healthcare Conference in
Miami , on Tuesday, March 10, 2026, at 8:00 a.m. ET.
These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.
Headquartered in
Contact:
Investors:
Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com
Media:
Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-march-2026-investor-conferences-302682778.html
SOURCE Insmed Incorporated
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.